Press release
Global Life Sciences Alliance Introduces GLSA Site Nexus to Streamline Study Access, Expert Support, and Collaboration for Clinical Research Sites
GLSA Site Nexus
Clinical research sites often face challenges identifying appropriate studies, managing feasibility, and accessing reliable operational support. GLSA Site Nexus was developed in direct response to these needs, offering a centralized hub that strengthens peer collaboration, streamlines study access, and supports site success.
"Sites told us they needed a private, trusted space to collaborate with peers, access expert guidance, and be matched with studies aligned to their capabilities," said Chris Matheus, Partner of GLSA. "GLSA Site Nexus delivers exactly that by bringing together experienced Site Experts, the Clinical Research Learning Network, and innovative solution partners."
"With GLSA Site Nexus, the member sites, whether new to clinical research or seasoned, can streamline study access, leverage expert support, and collaborate with peers in a secure, private environment," said Denise McNerney, Partner of GLSA.
The platform was developed with guidance and support from leading clinical research site experts, including Brian Norton (ClinTrial Networks); Judy Galindo (Save Our Sites / Latinos in Clinical Research); Julie Blasingim and Michele Baptista (UNIVO IRB); Matt Lowery (the Pathways Group); Joshua Webber (Clinical Research Learning Network); Marlyn Brookins, Ph.D. (Insightful Intellect); Arati Bhosale, BDS, MPH (StudySync Solutions); Gerald Munik, MD, FRCP (PI Enroll); Lisamarie O'Brien; Charlena Jackson (C.E. Jackson) (Divergent S.P.E.E.D).
Research sites interested in joining GLSA Site Nexus can learn more and request access through the Global Life Sciences Alliance website or by visiting Sites.GlobalLifeSciencesAlliance.com.
Denise McNerney
Partner
Global Life Sciences Alliance
5346 Megans Place Drive
Wilmington, NC 28409
United States
Email: theGLSA@glsa7.com
Phone: 267-663-2834
Website: Sites.GlobalLifeSciencesAlliance.com
Global Life Sciences Alliance (GLSA) is a collaborative resource serving the preclinical and clinical research community, connecting healthcare sites, sponsors, biotech, and pharma through a network of more than 200 partners. GLSA supports clinical research success by enabling collaboration, optimizing operations, and expanding access to meaningful life science resources.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Life Sciences Alliance Introduces GLSA Site Nexus to Streamline Study Access, Expert Support, and Collaboration for Clinical Research Sites here
News-ID: 4325461 • Views: …
More Releases from Global Life Sciences Alliance
Global Life Sciences Alliance Appoints Deb Kientop as Global Biotech Strategy Ex …
Expert Guidance to Help Biotechs Scale Smartly, From Funding to Exit
June 5, 2025 - Global Life Sciences Alliance (GLSA) is pleased to announce that seasoned biotech executive Deb Kientop has joined the organization as Global Biotech Strategy Executive, a pivotal role focused on guiding biotech companies through critical stages of development, growth, and exit planning.
With more than 25 years of experience in biotech commercialization, investment readiness, and corporate strategy, Deb…
Global Life Sciences Alliance Elevates Networking and Collaboration Efforts with …
Philadelphia, PA, January 12, 2024 - Global Life Sciences Alliance, a leader in the clinical research industry, is delighted to announce a significant expansion of its life science community efforts with the appointment of Bill Leone, a distinguished industry veteran, to spearhead networking and collaboration initiatives.
"At GLSA, we understand the paramount importance of connections and collaboration in advancing the landscape of clinical research. We are thrilled to welcome Bill Leone,…
More Releases for GLSA
ENDRA Life Sciences (NASDAQ: NDRA) Advances Health Tech (Alongside KYTX, RADX, G …
ENDRA Life Sciences (NASDAQ: NDRA) is emerging as a differentiated small-cap opportunity by combining breakthrough medical imaging innovation with a next-generation treasury strategy designed to improve capital efficiency and accelerate growth. The company, developer of the TAEUS Registered (Thermo-Acoustic Enhanced UltraSound) system for liver disease, is addressing one of healthcare's largest unmet needs while modernizing how it manages and deploys corporate capital.
TAEUS Registered Targets a Massive, Underdiagnosed Market
TAEUS Registered is…
Global Life Sciences Alliance Appoints Deb Kientop as Global Biotech Strategy Ex …
Expert Guidance to Help Biotechs Scale Smartly, From Funding to Exit
June 5, 2025 - Global Life Sciences Alliance (GLSA) is pleased to announce that seasoned biotech executive Deb Kientop has joined the organization as Global Biotech Strategy Executive, a pivotal role focused on guiding biotech companies through critical stages of development, growth, and exit planning.
With more than 25 years of experience in biotech commercialization, investment readiness, and corporate strategy, Deb…
Global Life Sciences Alliance Elevates Networking and Collaboration Efforts with …
Philadelphia, PA, January 12, 2024 - Global Life Sciences Alliance, a leader in the clinical research industry, is delighted to announce a significant expansion of its life science community efforts with the appointment of Bill Leone, a distinguished industry veteran, to spearhead networking and collaboration initiatives.
"At GLSA, we understand the paramount importance of connections and collaboration in advancing the landscape of clinical research. We are thrilled to welcome Bill Leone,…
